v3.26.3
Condensed Statements of Cash Flows - USD ($)
1 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2026
Cash flows from operating activities    
Net income (loss) $ (16,751) $ 5,357,548
Changes in operating assets and liabilities:    
Accounts Payable 71,751 1,224
Accrued Offering cost   (25,000)
Deferred offering cost (55,000) 126,763
Prepaid expense   (113,808)
Net cash provided by operating activities   5,346,727
Cash flows from investing activities    
Investment in trust account   (233,141,635)
Net cash used in investing activities   (233,141,635)
Cash flows from financing activities    
Promissory note 150,000  
Repayment of promissory note   (150,000)
Proceeds from sale of founder share 10,000  
Proceeds from sale of 22,750,000 units at $10 per unit in IPO, including over-allotment, net of offering cost.   225,855,053
Proceeds from sale of 275,000 units to Sponsor in private placement   2,750,000
Proceeds from sale of 1,000,000 $15 strike warrants in private placement   100,000
Proceeds from sale of 227,000 units to underwriters in private placement   100
Net cash provided by financing activities 160,000 228,555,153
Net increase in cash 160,000 760,245
Cash at beginning of period   37,181
Cash at end of period 160,000 797,426
Supplemental disclosure for non-cash financing activities    
Offering cost $ 55,000 $ 1,644,947